Incidence and predictors for cardiovascular events in patients with psoriatic arthritis

被引:85
|
作者
Eder, Lihi [1 ]
Wu, Ying [2 ]
Chandran, Vinod [1 ]
Cook, Richard [2 ]
Gladman, Dafna D. [1 ]
机构
[1] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada
[2] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada
基金
加拿大健康研究院;
关键词
Psoriatic Arthritis; Epidemiology; Atherosclerosis; Cardiovascular Disease; ATHEROSCLEROSIS RISK-FACTORS; POPULATION-BASED COHORT; RHEUMATOID-ARTHRITIS; SUBCLINICAL ATHEROSCLEROSIS; FRAMINGHAM RISK; DISEASE; INFLAMMATION; METAANALYSIS; PREVALENCE; INDIVIDUALS;
D O I
10.1136/annrheumdis-2015-207980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the incidence and risk factors of cardiovascular events in patients with psoriatic arthritis (PsA). Methods A cohort analysis was conducted involving patients recruited and followed over the period from 1978 to 2013 in a large PsA clinic. The participants were assessed at 6 to 12-month intervals according to a standard protocol. The collected information included demographics, lifestyle habits, medical history, medications use and PsA-related outcomes. The primary outcome was a composite major cardiovascular end point comprising myocardial infarction, ischaemic stroke, revascularisation or cardiovascular death. The association between the features of disease activity and the occurrence of cardiovascular events was assessed using Cox proportional hazard models. Results A total of 1091 patients with PsA were analysed. During the follow-up period, 104 cardiovascular events occurred. A considerable proportion of patients developed a cardiovascular event (19.8% of the patients by the age of 70 years and 30.1% of patient by the age of 80 years). No trend in the risk of developing cardiovascular events was observed over the decades from 1978 to 2013 (p=0.73). In multivariate analysis, the following variables were independent predictors of major cardiovascular events: hypertension (relative risk (RR) 1.81, p=0.015), diabetes (RR 2.72, p<0.001) and the number of dactylitic digits (RR 1.20, p<0.001). Sedimentation rate was a significant predictor only among women (RR 1.83, p=0.02). Conclusion A significant proportion of patients with PsA develop cardiovascular events during the course of their disease. Increased cardiovascular risk is associated with a combination of traditional cardiovascular risk factors and disease activity.
引用
收藏
页码:1680 / 1686
页数:7
相关论文
共 50 条
  • [21] Prediction of Cardiovascular Events in Patients with Ankylosing Spondylitis and Psoriatic Arthritis: Role of Lipoproteins in a High-risk Population
    Semb, Anne Grete
    Kvien, Tore K.
    DeMicco, David A.
    Fayyad, Rana
    Wun, Chuan-Chuan
    LaRosa, John
    Betteridge, John
    Pedersen, Terje R.
    Holme, Ingar
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (07) : 1433 - 1440
  • [22] Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction
    Cioffi, G.
    Giollo, A.
    Orsolini, G.
    Idolazzi, L.
    Carletto, A.
    Ognibeni, F.
    Dalbeni, A.
    Gatti, D.
    Rossini, M.
    Viapiana, O.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (03) : 420 - 427
  • [23] Cardiovascular risk markers in patients with psoriatic arthritis: A meta-analysis of literature studies
    Di Minno, Matteo Nicola Dario
    Ambrosino, Pasquale
    Lupoli, Roberta
    Di Minno, Alessandro
    Tasso, Marco
    Peluso, Rosario
    Tremoli, Elena
    ANNALS OF MEDICINE, 2015, 47 (04) : 346 - 353
  • [24] Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis
    Liew, Jean W.
    Ramiro, Sofia
    Gensler, Lianne S.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (03): : 369 - 389
  • [25] The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis
    Barra, Lillian J.
    Pope, Janet E.
    Hitchon, Carol
    Boire, Gilles
    Schieir, Orit
    Lin, Daming
    Thorne, Carter J.
    Tin, Diane
    Keystone, Edward C.
    Haraoui, Boulos
    Jamal, Shahin
    Bykerk, Vivian P.
    RHEUMATOLOGY, 2017, 56 (05) : 768 - 776
  • [26] Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis
    Radner, Helga
    Lesperance, Tamara
    Accortt, Neil A.
    Solomon, Daniel H.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (10) : 1510 - 1518
  • [27] DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study
    Lam, Steven Ho Man
    Cheng, Isaac T.
    Li, Edmund K.
    Wong, Priscilla
    Lee, Jolie
    Yip, Ronald Man-Lung
    Yim, Cheuk-Wan
    Ying, Shirley K.
    Li, Martin
    Li, Tena K.
    Lee, Alex Pui-Wai
    Tam, Lai-Shan
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (10) : 1320 - 1326
  • [28] EXTENDED REPORT Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review
    Jamnitski, Anna
    Symmons, Deborah
    Peters, Mike J. L.
    Sattar, Naveed
    MciInnes, Iain
    Nurmohamed, Michael T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (02) : 211 - 216
  • [29] Fragility Fractures Patients with Psoriatic Arthritis
    Del Puente, Antonio
    Esposito, Antonella
    Costa, Luisa
    Benigno, Carla
    Del Puente, Aurora
    Foglia, Francesca
    Oriente, Alfonso
    Bottiglieri, Paolo
    Caso, Francesco
    Scarpa, Raffaele
    JOURNAL OF RHEUMATOLOGY, 2015, 42 : 36 - 39
  • [30] Atherosclerosis in psoriatic arthritis
    Ramonda, R.
    Lo Nigro, A.
    Modesti, V.
    Nalotto, L.
    Musacchio, E.
    Iaccarino, L.
    Punzi, L.
    Doria, A.
    AUTOIMMUNITY REVIEWS, 2011, 10 (12) : 773 - 778